Literature DB >> 25766782

Chemokine CXCL-1: activity in the vitreous during proliferative vitreoretinopathy.

C Symeonidis1, S Androudi2, I Georgalas3, A Tzamalis1, N Chalvatzis1, T Rotsos3, E Souliou4, E Diza5, S A Dimitrakos1.   

Abstract

The aim of this study was to investigate CXCL-1 chemokine levels in the vitreous during rhegmatogenous retinal detachment (RRD) with and without proliferative vitreoretinopathy (PVR) and identify possible correlations with clinical parameters (extent and duration or RRD and PVR grade). Vitreous samples from patients with primary RRD with or without PVR were collected and assayed using a double antibody enzyme-linked immunosorbent assay (ELISA). Eleven vitreous samples from organ donors were employed as a control group. CXCL-1 levels were measured in 35 vitreous samples from 35 RRD patients. Mean CXCL-1 levels (64·82 ± 6·47 pg/ml) were significantly higher (P = 0·048) compared to controls. There was a significant positive correlation between CXCL-1 levels and the extent of the detachment (r = 0·794, P = 0·006). Peak CXCL-1 levels coincided with 3+ quadrant RRD, an interim of 29-60 days' duration and PVR grade B. Increased CXCL-1 levels may be indicative of mild inflammation in the detached retina and the adjacent vitreous. The results of the present study may provide novel insight into the complex interactions taking place during the early and late stages of RRD complicated by PVR.
© 2015 British Society for Immunology.

Entities:  

Keywords:  CXCL-1; GRO-α; proliferative vitreoretinopathy; rhegmatogenous retinal detachment; subretinal fluid

Mesh:

Substances:

Year:  2015        PMID: 25766782      PMCID: PMC4516449          DOI: 10.1111/cei.12627

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Chemokine CXCL-1 expression in the subretinal fluid during rhegmatogenous retinal detachment.

Authors:  Chrysanthos Symeonidis; Sofia Androudi; Tryfon Rotsos; Marilita M Moschos; Efimia Souliou; Stavros A Dimitrakos; Eudoxia Diza
Journal:  Ocul Immunol Inflamm       Date:  2013-12-19       Impact factor: 3.070

Review 2.  Chemokines and their receptors: orchestrating a fine balance between health and disease.

Authors:  Monika Sharma
Journal:  Crit Rev Biotechnol       Date:  2010-03       Impact factor: 8.429

Review 3.  Proliferative vitreoretinopathy: an overview.

Authors:  J C Pastor
Journal:  Surv Ophthalmol       Date:  1998 Jul-Aug       Impact factor: 6.048

4.  Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.

Authors:  Ahmed M Abu El-Asrar; Sofie Struyf; Dustan Kangave; Karel Geboes; Jo Van Damme
Journal:  Eur Cytokine Netw       Date:  2006-09       Impact factor: 2.737

5.  Interleukin-6 and the matrix metalloproteinase response in the vitreous during proliferative vitreoretinopathy.

Authors:  Chrysanthos Symeonidis; Eleni Papakonstantinou; Sofia Androudi; Tryfon Rotsos; Eudoxia Diza; Periklis Brazitikos; George Karakiulakis; Stavros A Dimitrakos
Journal:  Cytokine       Date:  2011-02-25       Impact factor: 3.861

6.  Analysis of the molecular biologic milieu of the vitreous in proliferative vitreoretinopathy.

Authors:  Edward J Wladis; Naomi S Falk; Bibiana V Iglesias; Paul M Beer; Edmund J Gosselin
Journal:  Retina       Date:  2013-04       Impact factor: 4.256

7.  Monocyte-induced cytokine expression in cultured human retinal pigment epithelial cells.

Authors:  G J Jaffe; W L Roberts; H L Wong; A D Yurochko; G J Cianciolo
Journal:  Exp Eye Res       Date:  1995-05       Impact factor: 3.467

8.  Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases.

Authors:  Takeru Yoshimura; Koh-hei Sonoda; Mika Sugahara; Yasutaka Mochizuki; Hiroshi Enaida; Yuji Oshima; Akifumi Ueno; Yasuaki Hata; Hiroki Yoshida; Tatsuro Ishibashi
Journal:  PLoS One       Date:  2009-12-04       Impact factor: 3.240

9.  The classification of retinal detachment with proliferative vitreoretinopathy.

Authors: 
Journal:  Ophthalmology       Date:  1983-02       Impact factor: 12.079

10.  Prevalence and risk factors for proliferative vitreoretinopathy in eyes with rhegmatogenous retinal detachment but no previous vitreoretinal surgery.

Authors:  Wendy Tseng; Rafael T Cortez; Gema Ramirez; Sandra Stinnett; Glenn J Jaffe
Journal:  Am J Ophthalmol       Date:  2004-06       Impact factor: 5.258

View more
  2 in total

1.  Oxidative stress enhanced the transforming growth factor-β2-induced epithelial-mesenchymal transition through chemokine ligand 1 on ARPE-19 cell.

Authors:  I-Hui Yang; Jong-Jer Lee; Pei-Chang Wu; Hsi-Kung Kuo; Yu-Hsia Kuo; Hsiu-Mei Huang
Journal:  Sci Rep       Date:  2020-03-04       Impact factor: 4.379

2.  Vitreous Cytokine Expression and a Murine Model Suggest a Key Role of Microglia in the Inflammatory Response to Retinal Detachment.

Authors:  Lee Kiang; Bing X Ross; Jingyu Yao; Sumathi Shanmugam; Chris A Andrews; Sean Hansen; Cagri G Besirli; David N Zacks; Steven F Abcouwer
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-07-02       Impact factor: 4.799

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.